Predicting Hepatic Decompensation in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease‐Related Cirrhosis: The ABID‐LSM Model

Documenti analoghi

• Editorial: ABID‐LSM–A Promising Model for Predicting Decompensation Risk in MASLD Cirrhosis
  di: Eduardo Vilar‐Gomez, et al.
  Pubblicazione: (2025)
• Patient Plasma‐Induced Neutrophil Dysfunction Is Associated With Infection Risk and Mortality in Patients With Acute Decompensation of Cirrhosis
  di: Supachaya Sriphoosanaphan, et al.
  Pubblicazione: (2025)
• Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease
  di: Soroor Owrangi, et al.
  Pubblicazione: (2024)
• Editorial: Diabetes Management in Cirrhosis—The Window of Opportunity Before Decompensation
  di: Thanawin Pramotedham, et al.
  Pubblicazione: (2026)
• Unstable Recompensation: An Intermediate Subtype in Patients With HBV ‐Related Decompensated Cirrhosis
  di: Shuai Xia, et al.
  Pubblicazione: (2025)